XENE
Xenon Pharmaceuticals Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding):
keluasan pemegang -6.7% ·
aliran saham -7.9% ·
posisi baru bersih -7.1%
— formula
Distribusi luas — penurunan saham dan lebih sedikit pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 114 | +7 | 55.64M | $3.35B | +11 | −4 |
| Q1 2026 | 110 | +12 | 59.13M | $3.41B | +18 | −6 |
| Q4 2025 | 96 | 0 | 51.65M | $2.31B | +1 | −1 |
| Q3 2025 | 17 | 0 | 29.02M | $1.17B | — | — |
| Q2 2025 | 14 | -1 | 23.81M | $745.12M | +1 | −2 |
| Q1 2025 | 12 | +1 | 10.74M | $360.22M | +1 | — |
| Q4 2024 | 11 | -1 | 10.24M | $401.45M | — | −1 |
| Q3 2024 | 11 | 0 | 11.68M | $459.86M | — | — |
| Q2 2024 | 11 | — | 11.68M | $455.36M | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 8.88M | — | $278.08M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 8.88M | — | $278.08M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 8.88M | — | $278.08M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (pasif) | 5.37M | — | $167.93M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (pasif) | 5.37M | — | $167.93M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (pasif) | 5.37M | — | $167.93M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (pasif) | 5.37M | — | $167.93M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (pasif) | 5.37M | — | $167.93M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (pasif) | 5.37M | — | $167.93M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (pasif) | 5.37M | — | $167.93M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (pasif) | 5.37M | — | $167.93M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (pasif) | 5.37M | — | $167.93M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (pasif) | 5.37M | — | $167.93M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (pasif) | 5.37M | — | $167.93M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (pasif) | 5.37M | — | $167.93M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (pasif) | 5.37M | — | $167.93M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (pasif) | 5.37M | — | $167.93M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (pasif) | 5.37M | — | $167.93M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Wellington Management ✦ | 2.17M | -42.6% | $68.07M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 20 | Wellington Management ✦ | 2.17M | -42.6% | $68.07M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 21 | Wellington Management ✦ | 2.17M | -42.6% | $68.07M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 22 | Wellington Management ✦ | 2.17M | -42.6% | $68.07M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 23 | Wellington Management ✦ | 2.17M | -42.6% | $68.07M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 24 | State Street Global Advisors ✦ (pasif) | 1.38M | +351.7% | $43.21M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 25 | Adage Capital Partners ✦ | 1.29M | -32.6% | $40.38M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 26 | Marshall Wace ✦ | 1.02M | +34.6% | $31.93M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | Geode Capital Management ✦ (pasif) | 970.34K | +1294.2% | $30.37M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | Geode Capital Management ✦ (pasif) | 970.34K | +1294.2% | $30.37M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 29 | Millennium Management ✦ | 882.84K | +277.2% | $27.63M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | The Vanguard Group ✦ (pasif) | 873.23K | — | $27.33M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | The Vanguard Group ✦ (pasif) | 873.23K | — | $27.33M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | The Vanguard Group ✦ (pasif) | 873.23K | — | $27.33M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | The Vanguard Group ✦ (pasif) | 873.23K | — | $27.33M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | The Vanguard Group ✦ (pasif) | 873.23K | — | $27.33M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Capital World Investors ✦ | 655.74K | -70.5% | $20.52M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 36 | D. E. Shaw & Co. ✦ | 141.78K | -6.8% | $4.44M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 37 | Citadel Advisors ✦ | 120.05K | -82.5% | $3.76M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 38 | T. Rowe Price ✦ | 37.94K | Baru | $1.19M | 0.0% | New | 1 | SEC ↗ |
| 39 | T. Rowe Price ✦ | 37.94K | Baru | $1.19M | 0.0% | New | 1 | SEC ↗ |
| 40 | Renaissance Technologies ✦ | 8.60K | -94.4% | $269,180 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| T. Rowe Price | $1.19M | 0.0% |
| T. Rowe Price | $1.19M | 0.0% |
Telah keluar
| Two Sigma Investments | $7.95M | adalah 0.0% |
| Point72 Asset Management | $7.04M | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1 pemegang, 129.80K saham, $7,547 dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Director · 10.00K lbr · $640,550
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi